These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 17620882)

  • 21. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
    Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
    Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetics and present therapy options in Parkinson's disease: a review].
    Bereznai B; Molnar MJ
    Ideggyogy Sz; 2009 May; 62(5-6):155-63. PubMed ID: 19579663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of parkinsonism.
    Bonifati V
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S233-41. PubMed ID: 18267242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.
    Scarciolla O; Brancati F; Valente EM; Ferraris A; De Angelis MV; Valbonesi S; Garavaglia B; Uncini A; Palka G; Stuppia L; Dallapiccola B
    Mov Disord; 2007 Nov; 22(15):2274-8. PubMed ID: 17914726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics and epigenetics of Parkinson's disease.
    Coppedè F
    ScientificWorldJournal; 2012; 2012():489830. PubMed ID: 22623900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
    Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
    Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What genetics tells us about the causes and mechanisms of Parkinson's disease.
    Corti O; Lesage S; Brice A
    Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Function study advances of Parkinson disease related genes].
    Wang XM; Wang DQ; Wang XY
    Yi Chuan; 2010 Aug; 32(8):779-84. PubMed ID: 20709674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease].
    Iwatsubo T; Ito G; Takatori S; Hannno Y; Kuwahara T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):899-901. PubMed ID: 16447757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the genetics of Parkinson's disease.
    Gasser T
    Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease: insights from pathways.
    Cookson MR; Bandmann O
    Hum Mol Genet; 2010 Apr; 19(R1):R21-7. PubMed ID: 20421364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of Parkinson's disease.
    Morris HR
    Ann Med; 2005; 37(2):86-96. PubMed ID: 16026116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular genetics of PINK1].
    Funayama M; Hattori N
    Brain Nerve; 2007 Aug; 59(8):831-8. PubMed ID: 17713119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
    van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
    Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral testing regimens in genetic-based animal models of Parkinson's disease: cogencies and caveats.
    Bury A; Pienaar IS
    Neurosci Biobehav Rev; 2013 Jun; 37(5):846-59. PubMed ID: 23558176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.
    Nuytemans K; Theuns J; Cruts M; Van Broeckhoven C
    Hum Mutat; 2010 Jul; 31(7):763-80. PubMed ID: 20506312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.
    Quattrone A; Bagnato A; Annesi G; Novellino F; Morgante L; Savettieri G; Zappia M; Tarantino P; Candiano IC; Annesi F; Civitelli D; Rocca FE; D'Amelio M; Nicoletti G; Morelli M; Petrone A; Loizzo P; Condino F
    Mov Disord; 2008 Jan; 23(1):21-7. PubMed ID: 17975812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autosomal recessive mutations in the development of Parkinson's disease.
    Lopez G; Sidransky E
    Biomark Med; 2010 Oct; 4(5):713-21. PubMed ID: 20945983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
    Trancikova A; Tsika E; Moore DJ
    Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.